Clincosm LogoSign in Get a demo

gastroesophageal junction adenocarcinoma

Showing 51 - 75 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in United

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • +3 more
  • Coral Gables, Florida
  • +4 more
Mar 1, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Trastuzumab, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
  • +9 more
Mar 11, 2022

A Multicenter Cancer Biospecimen Collection Study

Recruiting
  • Cancer of Head and Neck
  • +10 more
  • OncoPrism™ assay
  • San Francisco, California
    Curebase
Mar 8, 2022

Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Japan, Korea, Republic of, Taiwan

Completed
Has Results
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Akashi, Japan
  • +33 more
Feb 23, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
Feb 21, 2022

Gastroesophageal Junction Adenocarcinoma, Stage IB Esophageal Adenocarcinoma AJCC v7, Stage II Esophageal Adenocarcinoma AJCC v7

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT041 autologous CAR T-cell injection
  • Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）
  • Hefei, Anhui, China
  • +9 more
Feb 13, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-ADC)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Feb 10, 2022

Gastric Tumor, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Dresden, Heidelberg (Biopsy)

Active, not recruiting
  • Gastric Neoplasm
  • +4 more
  • Biopsy
  • Dresden, Germany
  • +1 more
Feb 22, 2022

Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • Oxaliplatin; Capecitabine
  • Oxaliplatin; Capecitabine; concurrent radiotherapy
  • Shijiazhuang, Hebei, China
    Department of General Surgery
Feb 4, 2022

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-MAB)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jan 24, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022

Gastric Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte (Best Practice, Questionnaire Administration,

Recruiting
  • Gastric Carcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jan 12, 2022

Gastric Tumors, Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (Camrelizumab, Pyrotinib, Capecitabine)

Not yet recruiting
  • Gastric Neoplasms
  • Gastroesophageal Junction Adenocarcinoma
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Oct 27, 2021

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,

Completed
Has Results
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Fayetteville, Arkansas
  • +134 more
Jul 29, 2021

Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)

Active, not recruiting
  • Metastatic Cancer
  • +4 more
  • VE800
  • +2 more
  • Scottsdale, Arizona
  • +17 more
Jun 22, 2021

Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,

Recruiting
  • Pancreatic Adenocarcinoma
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Jun 7, 2021

Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Chicago (Pembrolizumab

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • +2 more
  • Pembrolizumab Injection
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Korea, Republic of (Ramucirumab and paclitaxel, Taxane,

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Ramucirumab and paclitaxel
  • Taxane, irinotecan, or fluoropyrimidine-based single or combined chemotherapy
  • Anyang, Korea, Republic of
  • +8 more
Jun 1, 2021

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

Completed
  • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
  • +5 more
  • S-1 de-escalation
  • Chemotherapy by Investigator's choice
  • Heidelberg, Baden-Württemberg, Germany
    NCT-Med. Onkologie
Mar 25, 2021

Gastroesophageal Junction Adenocarcinoma, Advanced Gastric Carcinoma Trial in Edmonton (Irinotecan, Oxaliplatin, TAS 102

Not yet recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Advanced Gastric Carcinoma
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 18, 2021

Gastric Cancer, Peritoneal Carcinomatosis, Gastroesophageal Junction Adenocarcinoma Trial in Orange (Paclitaxel, Leucovorin,

Recruiting
  • Gastric Cancer
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Mar 5, 2021

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Raltitrexed, Paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences
Jan 29, 2021